Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study.

Ballantyne CM, Hoogeveen RC, Raya JL, Cain VA, Palmer MK, Karlson BW; GRAVITY Study Investigators.

Atherosclerosis. 2014 Jan;232(1):86-93. doi: 10.1016/j.atherosclerosis.2013.10.022. Epub 2013 Nov 1.

PMID:
24401221
2.

Clopidogrel in infants with systemic-to-pulmonary-artery shunts.

Wessel DL, Berger F, Li JS, Dähnert I, Rakhit A, Fontecave S, Newburger JW; CLARINET Investigators.

N Engl J Med. 2013 Jun 20;368(25):2377-84. doi: 10.1056/NEJMoa1114588.

3.

Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.

Goldhaber SZ, Leizorovicz A, Kakkar AK, Haas SK, Merli G, Knabb RM, Weitz JI; ADOPT Trial Investigators.

N Engl J Med. 2011 Dec 8;365(23):2167-77. doi: 10.1056/NEJMoa1110899. Epub 2011 Nov 13.

4.

Irbesartan in patients with atrial fibrillation.

ACTIVE I Investigators, Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ.

N Engl J Med. 2011 Mar 10;364(10):928-38. doi: 10.1056/NEJMoa1008816.

5.

Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S.

N Engl J Med. 2009 May 14;360(20):2066-78. doi: 10.1056/NEJMoa0901301. Epub 2009 Mar 31.

6.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.

7.

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.

POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P.

Lancet. 2008 May 31;371(9627):1839-47. doi: 10.1016/S0140-6736(08)60601-7. Epub 2008 May 12.

8.

Off-pump coronary artery bypass grafting does not reduce lymphocyte activation.

Blacher C, Neumann J, Jung LA, Lucchese FA, Ribeiro JP.

Int J Cardiol. 2005 Jun 8;101(3):473-9.

PMID:
15907417
9.
10.

[Guidelines for pulmonary embolism].

Volschan A, Caramelli B, Gottschall CA, Blacher C, Casagrande EL, Lucio Ede A, Manente ER, Mesquita ET, Bodanese LC, Rocha MS.

Arq Bras Cardiol. 2004 Aug;83 Suppl 1:1-8. Epub 2004 Aug 6. Portuguese. No abstract available. Erratum in: Arq Bras Cardiol. 2004 Oct;83(4):364.

11.

Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery.

Lúcio Ede A, Flores A, Blacher C, Leães PE, Lucchese FA, Ribeiro JP.

Arq Bras Cardiol. 2004 Jan;82(1):42-46, 37-41. Epub 2004 Feb 12. English, Portuguese.

12.

[B-type natriuretic peptide and cardiovascular disease].

da Silva LB, Ferreira CA, Blacher C, Leáes P, Haddad H.

Arq Bras Cardiol. 2003 Nov;81(5):529-39. Epub 2003 Dec 1. Review. English, Portuguese. No abstract available.

13.

[Coronary bypass without extracorporeal circulation. A technique in search of scientific evidence].

Blacher C, Ribeiro JP.

Arq Bras Cardiol. 2003 Jun;80(6):656-62. Epub 2003 Jul 2. Portuguese. No abstract available.

14.

Primary cardiac angiosarcoma. A therapeutical dilemma.

Frota Filho JD, Lucchese FA, Leães P, Valente LA, Vieira MS, Blacher C.

Arq Bras Cardiol. 2002 Jun;78(6):586-91. Review. English, Portuguese.

PMID:
12185858
15.

Partial left ventriculectomy: overall and late results in 44 class IV patients with 4-year follow-up.

Lucchese FA, Frota Filho JD, Blacher C, Pereira W, Lucio E, Beck L, Leonetti LA, Leães PE.

J Card Surg. 2000 May-Jun;15(3):179-85.

PMID:
11414603
16.

End-stage heart failure: is there a role for the Batista procedure?

Frota Filho JD, Pereira WM, Leães PE, Blacher C, Jung LA, Lucchese F.

Heart Surg Forum. 1998;1(1):41-8.

PMID:
11276439
17.

Postoperative necrotizing fasciitis of the thorax in cardiac surgery.

Frota Filho JD, Drews C, Leães P, Blacher C, Tostes F, Delatorre N, Vieira M, Lúcio E, Pereira W, Sales M, Lobo R, Stuermer R, Tanaka N, Portugal L, Lucchese F.

Arq Bras Cardiol. 2001 Mar;76(3):245-54. English, Portuguese.

18.

Evaluation of the treadmill stress testing for risk stratification after acute myocardial infarction.

Blacher C, Manfroi W, Fernandes BS.

Arq Bras Cardiol. 1999 Dec;73(6):527-36. Review. English, Portuguese. No abstract available.

19.

Holt-Oram syndrome revisited. Two patients in the same family.

Frota Filho JD, Pereira W, Leiria TL, Vallenas M, Leães PE, Blacher C, Lúcio E, Lucchese FA.

Arq Bras Cardiol. 1999 Nov;73(5):429-34.

20.

[Involvement of pulmonary function in patients treated with rotated chest muscle flap surgery for the treatment of sternal wound complications after heart surgery].

Blacher C, Leães PE, Parisotto A, Bendl AL, Boeira J, Lucchese FA.

Arq Bras Cardiol. 1996 Oct;67(4):243-7. Portuguese.

PMID:
9181722
Items per page

Supplemental Content

Loading ...
Write to the Help Desk